Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |